Aug 21, 2026
•
4 min read
Plus, Tilray flexes EU capacity
Aug 20, 2026
Plus, Congress demands rescheduling answers
Aug 19, 2026
2 min read
Plus, DEA admits cannabis is mostly safe
Premium
Aug 18, 2026
Curaleaf is bringing its hostile bid for Aurora directly to shareholders. The prize? Medical cannabis exports to the EU.
Plus, Challenger Brands in Pennsylvania
Aug 17, 2026
Plus, Platform Cannabis Advisors raises $1.2 million
Aug 14, 2026
Plus, $GLAS results
Aug 13, 2026
3 min read
Curaleaf CEO Boris Jordan says he tried to play nice before taking its $4-per-share Aurora bid public.
Plus, Aurora fires back at Curaleaf
Aug 12, 2026
The Texas Senate candidate's opposition to the state's new hemp ban shows how cannabis policy still works as a wedge issue in unlikely places.
Plus, Spherex joins Cultivated Live
Aug 11, 2026
Plus, $VFF exports a lot of cannabis
Aug 10, 2026
Plus, hemp ban delayed for a month
Aug 7, 2026
Plus, Cronos Group CEO on Cultivated Live
Aug 6, 2026
Plus, in case you missed it >> Banker on Call
Aug 5, 2026
Plus, July's New York Brand Power rankings
Aug 4, 2026
Plus, Talarico, THC, and Texas
Aug 3, 2026
Plus, Senate may delay hemp ban
